Etoposide inhibited the biosynthesis of DNA in gastric cancer cells, but a stronger antiproliferative effect was indicated after 24-hour incubation with a chemotherapeutic agent and anti-HER2 monoclonal antibodies, especially with pertuzumab. This evidence concerns the gene ERBB2 and gastric cancer.